Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 22 out of 100. Health systems and care delivery

Topic: Risk, prevention and care in population studies

And, she noted, data from the 2009-2011 Medical Expenditure Panel Survey have shown that “high-need adults spent more on health care but were less likely to report that the health system works for them.” Abrams said it is important to specifically target this population: assess their needs; develop effective care plans; engage patients and family members in managing their care; connect patients to follow-up and support services; coordinate care with all providers; and monitor patients' progress. Boling concluded that, in many cases, the best way to care for these low-income, high-needs patients is house calls. Boling, whose site is one of the IAH demonstration participants, said that according to data from the Centers for Medicare & Medicaid Services (CMS), IAH demonstration year one results (June 2015) showed savings of more than $25 million on 8,400 high-cost beneficiaries, for more than $3,000 saved per beneficiary. Asked how travel time to and from housebound patients can be cost-effective for physicians, he said, “The payment has to be worth their while.” Katherine Hayes, JD, Director of Health Policy for the Bipartisan Policy Center, agreed with Abrams that misaligned financial incentives are often a barrier to the sustainability and spread of successful models of care for high-needs, high-cost older patients. “While changing federal reimbursement policy is not the only solution, without change, financial incentives are a significant barrier to sustainability and spread of successful models,” she said.

Key findings

Why it matters

This report describes care approaches for high-cost, high-need patients, including assessing needs, developing care plans, engaging patients and families, and coordinating care. It notes that a demonstration showed savings on high-cost beneficiaries, but that misaligned financial incentives are often a barrier to spreading successful care models.

Study details

How this study scored 22/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 0 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 1 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 1 of 4; Institution's track record left out, no data; Multi-centre collaboration 0 of 3; Indexed in PubMed 1 of 2; Free to read 0 of 2. 21 of the 97 points it could be judged on, which is 22 of 100. Total 22 of 100.21 of the 97 points we could judge = 22 of 100

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it. We have no data on institution's track record, so that was left out: it earned 21 of the 97 points we could judge it on, which is 22 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Oncology Times)
Journal's citation record 0 / 4 Oncology Times: journal h-index 24 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 1 / 5 2016 — within 20 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 12 year(s) since 2016
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 1 / 4 Last-listed author Peggy Eastman: h-index 5 (OpenAlex, whole career)
Institution's track record — / 3 No institution listed in OpenAlex — left out of this score
Multi-centre collaboration 0 / 3 OpenAlex lists 0 institution(s) in 0 countries — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 0 / 2 Behind a paywall — scores zero
Points 21 / 97 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 21 of the 97 points we could judge it on is 22 out of 100.
Total 22 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Eastman, P. (2016). Improving Care for High-Cost, High-Need Patients. Oncology Times. https://doi.org/10.1097/01.cot.0000503429.93604.60

Vancouver

Eastman P. Improving Care for High-Cost, High-Need Patients. Oncology Times. 2016. doi:10.1097/01.cot.0000503429.93604.60.

BibTeX

@article{eastman2016-738a4899,
  author  = {Eastman, Peggy},
  title   = {{Improving Care for High-Cost, High-Need Patients}},
  journal = {Oncology Times},
  year    = {2016},
  doi     = {10.1097/01.cot.0000503429.93604.60},
  url     = {https://doi.org/10.1097/01.cot.0000503429.93604.60}
}

Related studies in Health systems and care delivery

Also in Health systems and care delivery

172 studies in the library are filed under Health systems and care delivery with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Health systems and care delivery hub.

Similar studies

More on Health systems and care delivery

See all studies in Health systems and care delivery →